tiprankstipranks
Trending News
More News >
Capricor Therapeutics (CAPR)
NASDAQ:CAPR

Capricor Therapeutics (CAPR) Revenue

Compare
1,234 Followers

Capricor Therapeutics Revenue

Capricor Therapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 11.13M, Increased -16.89%. In the fiscal year ending Dec 31, 2024, Capricor Therapeutics had annual revenue of 22.27M with -11.55% growth.
Revenue (ttm)
11.13M
Revenue Growth
-52.08%
P/S Ratio
59.87
Revenue/Employee
$139,190
Employees
160
Market Cap
$1.33B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
22.27M-2.91M+88.45%
Dec 31, 2023
25.18M22.63M+986.81%
Dec 31, 2022
2.55M2.31M+1,041.85%
Dec 31, 2021
244.90K-65.35K+78.94%
Dec 31, 2020
310.25K-694.78K+30.87%
Dec 31, 2019
1.01M-666.33K+60.13%
Dec 31, 2018
1.67M304.17K+122.25%
Dec 31, 2017
1.37M-1.82M+42.86%
Dec 31, 2016
3.19M